SciNeuro concludes dosing in study of Alzheimer’s therapeutic
The study will assess the tolerability, safety, pharmacokinetics, and pharmacodynamics of the therapy in healthy subjects.
Company News
Neurogene doses two paediatric patients in trial of Rett Syndrome therapy
Acadia starts Phase III study of PWS therapy
Cybin reports positive results from major depressive disorder trial
Arrowhead seeks regulatory clearance for Type 1 myotonic dystrophy trial
Merck reports data from Phase III pneumococcal vaccine trial
FDA grants IND clearance for Carisma’s solid tumour cell therapy trial
TOLREMO doses first subject in Phase I trial of TT125-802
